LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression

por Montañez-Wiscovich, ME, Seachrist, DD, Landis, MD, Visvader, J, Andersen, B, Keri, RA
Publicado 2009

Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer

por Merino, D., Weber, T. S., Serrano, A., Vaillant, F., Liu, K., Pal, B., Di Stefano, L., Schreuder, J., Lin, D., Chen, Y., Asselin-Labat, M. L., Schumacher, T. N., Cameron, D., Smyth, G. K., Papenfuss, A. T., Lindeman, G. J., Visvader, J. E., Naik, S. H.
Publicado 2019

Publisher Correction: Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer

por Merino, D., Weber, T. S., Serrano, A., Vaillant, F., Liu, K., Pal, B., Di Stefano, L., Schreuder, J., Lin, D., Chen, Y., Asselin-Labat, M. L., Schumacher, T. N., Cameron, D., Smyth, G. K., Papenfuss, A. T., Lindeman, G. J., Visvader, J. E., Naik, S. H.
Publicado 2019

Expression of LMO4 and outcome in pancreatic ductal adenocarcinoma

por Murphy, N C, Scarlett, C J, Kench, J G, Sum, E Y M, Segara, D, Colvin, E K, Susanto, J, Cosman, P H, Lee, C-S, Musgrove, E A, Sutherland, R L, Lindeman, G J, Henshall, S M, Visvader, J E, Biankin, A V
Publicado 2008